In vivo modeling of patient genetic heterogeneity identifies new ways to target cholangiocarcinoma.

Nicholas Younger, Mollie Wilson, Anabel Martinez Lyons, Ed Jarman, Alison M Meynert, Graeme R Grimes, Konstantinos Gournopanos, Scott Waddell, Peter Tennant, David Wilson, Rachel V Guest, Stephen J Wigmore, Juan Carlos Acosta, Timothy J. Kendall, Martin S Taylor, Duncan Sproul, Pleasantine Mill, Luke Boulter

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCancer Research
Early online date24 Jan 2022
Publication statusE-pub ahead of print - 24 Jan 2022

Cite this